Domestic paragraph 2 and global paragraph 3 ｜ This vaccine in Heilongjiang Province is first inoculated in Heilongjiang Province

On the 17th, the world's first dual -carrier 13 -valent pneumonia vaccine was first vaccinated in Harbin, Heilongjiang. This is a 13 -valent pneumonia vaccine approved and approved in the world's third paragraph in China, bringing more effective protection to infants and children in Heilongjiang Province.

The 13 -carrier 13 -valent pneumonia vaccine listed in our province was independently developed by Shenzhen Kangtai Biological Products Co., Ltd., a wholly -owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. The combination of polysaccharides in polysaccharides of pneumococcus film pods is the world's first dual -carrier 13 -valent 13 -valent pneumonia vaccine. According to Li Shuli, director of the Harxi Community Health Service Center of Nangang District, the use of dual -carrier can reduce the inhibitory effect of the luggage induced, which can effectively avoid the adverse effects caused by excessive amounts of single carrier. Simply put, dual -carrier can make the vaccine better immune and longer immune time. At the same time, the vaccine has good safety and mild adverse reactions. In clinical trials, the incidence of adverse reactions is lower than the control group products.

Double -carrier 13 -valent pneumonia vaccines have good effects on infants and children at 6 weeks to 5 years (a few years old), which greatly relaxes the age limit of vaccination. Domestic dual -carrier 13 -valent pneumonia vaccine not only breaks through innovation in technical. In the case of the effectiveness and safety of the vaccine, its price is only 458 yuan/dose, which is more than 30%cheaper than imported vaccines. Successful, this undoubtedly brings more convenience and benefits to domestic families. Professor Tian Zhiliang, a pediatric expert of the Second Affiliated Hospital of Harbin Medical University, introduced that "13 -valent pneumonia vaccines can protect children from the most common and most harmful of the 13 pathogenic serum types. The most economical, the safest and effective way. "

Source: Harbin News Network

Reporter: Sun Yan

Edit: Wang Yue

- END -